Ekso Bionics Holdings, Inc. (EKSO)

NASDAQ: EKSO · IEX Real-Time Price · USD
2.50
+0.62 (32.98%)
At close: Dec 29, 2023, 4:00 PM
2.55
+0.05 (2.00%)
After-hours: Dec 29, 2023, 7:58 PM EST

Company Description

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally.

It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.

The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.

The company also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therap, an adjustable and lower-limb powered exoskeleton; and Ekso Indego Personal, a powered lower limb orthosis.

It has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in San Rafael, California.

Ekso Bionics Holdings, Inc.
Ekso Bionics Holdings logo
Country United States
Founded 2005
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 72
CEO Scott G. Davis

Contact Details

Address:
101 Glacier Point, Suite A
San Rafael, California 94901
United States
Phone 510-984-1761
Website eksobionics.com

Stock Details

Ticker Symbol EKSO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001549084
CUSIP Number 282644301
ISIN Number US2826443010
SIC Code 3569

Key Executives

Name Position
Scott G. Davis Chief Executive Officer and Director
Jerome Wong Corporate Controller, Corp. Secretary and Chief Financial Officer
Rachael Anderson Global Director of Marketing and Strategic Growth
Anthony Pratt Vice President of Sales
Ann Cookson HR Director
Foon Lim Chwee President of APAC
Jason C. Jones Senior Vice President of Product Development
Stephan Aderhold Senior Vice President and GM of EMEA

Latest SEC Filings

Date Type Title
Nov 14, 2023 8-K Current Report
Oct 26, 2023 10-Q Quarterly Report
Oct 26, 2023 8-K Current Report
Sep 29, 2023 8-K Current Report
Aug 18, 2023 8-K Current Report
Jul 28, 2023 8-K Current Report
Jul 28, 2023 424B5 Filing
Jul 27, 2023 10-Q Quarterly Report
Jul 27, 2023 8-K Current Report
Jun 20, 2023 EFFECT Notice of Effectiveness